BTAI BioXcel Therapeutics, Inc.
Price Chart
Executive Summary
Analysis based on filing metadata only — document content was unavailable. The filing is an 8-K with Items 1.01 (Entry into Material Agreement) and 9.01 (Financial Statements and Exhibits), suggesting a potential new agreement or contract was announced, but no details are accessible to assess its nature or impact.
Actionable Insight
Wait for the actual filing to be available to assess the material agreement's impact. Monitor for press releases or investor communications from BioXcel Therapeutics that may disclose further details.
Key Facts
- Filing type is 8-K, indicating a material event.
- Items reported: 1.01 (Entry into Material Agreement) and 9.01 (Financial Statements and Exhibits).
- No document content available to determine the agreement's nature, parties involved, or financial terms.
- Market cap of BTAI is $34M as per snapshot.
Financial Impact
Unknown — no financial details available from the filing.
Risk Factors
- Inability to assess potential dilution, cash impact, or strategic implications due to missing data.
- Risk of delayed reaction if the agreement is significant and already priced in by the market.
Market Snapshot
Documents Analyzed
Report based on filing metadata.
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 20, 2026
today
|
144
| — | awaiting T+20 | — | — |
|
May 15, 2026
5d ago
|
8-K
| — | awaiting T+20 | — | — |
|
May 15, 2026
5d ago
|
Press Release
| $1.22 awaiting T+20 | awaiting T+20 | — | $1.09 (+10.29%) |
|
Apr 17, 2026
4w ago
|
8-K
| $1.20 $1.13 | ▲ +5.83% | ▲ +10.04% | $1.09 (+9.17%) |
|
Mar 27, 2026
7w ago
|
Press Release
| $1.26 $1.09 | ▼ −13.49% | ▼ −26.23% | $1.09 (−13.49%) |
|
Mar 11, 2026
10w ago
|
8-K
| $1.55 $1.06 | ▼ −31.61% | ▼ −33.59% | $1.09 (−29.68%) |
|
Mar 10, 2026
10w ago
|
Press Release
| $1.55 $1.10 | ▲ +29.03% | ▲ +28.88% | $1.09 (+29.68%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access